As of June 15, 2025, Carl Zeiss Meditec AG (AFX.DE) reports a EV/EBITDA of 15.80.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Carl Zeiss Meditec AG's EV/EBITDA to Peers
To better understand Carl Zeiss Meditec AG's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Carl Zeiss Meditec AG (AFX.DE) | 15.80 |
| Revenio Group Oyj (REG1V.HE) | 22.66 |
| Straumann Holding AG (STMN.SW) | 22.53 |
| CellaVision AB (CEVI.ST) | 21.92 |
| Medistim ASA (MEDI.OL) | 20.70 |
| Ambu A/S (AMBU B.CO) | 19.69 |
Compared to its competitors, Carl Zeiss Meditec AG's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.